In two major clinical trials, researchers found cell therapy dramatically outperformed the standard of care used for the past few decades to counter a common …

Bristol Myers’ acquisition of Celgene immediately made the big pharma a top player in the development of cancer cell therapies. Since the deal closed, Bristol …